Evidence map›Paper›PMID 39796219›Full record

ArticleInternational journal of molecular sciences2025

Quantitative Analysis of Pseudogene-Associated Errors During Germline Variant Calling.

Artem Podvalnyi, Arina Kopernik, Mariia Sayganova, Mary Woroncow, Gauhar Zobkova, Anna Smirnova, Anton Esibov, Andrey Deviatkin, Pavel Volchkov, Eugene Albert

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Artem PodvalnyiFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.
Arina KopernikFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.
Mariia SayganovaFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.
Mary WoroncowFaculty of Fundamental Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Gauhar ZobkovaEvogen LLC, 115191 Moscow, Russia.
Anna SmirnovaEvogen LLC, 115191 Moscow, Russia.
Anton EsibovFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.
Andrey DeviatkinFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.ORCID 0000-0003-0789-4601
Pavel VolchkovFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.
Eugene AlbertFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.ORCID 0000-0001-7950-0945

Funding

Ministry of Science and Higher Education of the Russian Federation 075-03-2024-117/6, project # FSMG-2024-0029Ministry of Science and Higher Education of the Russian Federation FGFG-2024-0002, agreement #075-03-2024-323/3
6 · The paper itself

Abstract

A pseudogene is a non-functional copy of a protein-coding gene. Processed pseudogenes, which are created by the reverse transcription of mRNA and subsequent integration of the resulting cDNA into the genome, being a major pseudogene class, represent a significant challenge in genome analysis due to their high sequence similarity to the parent genes and their frequent absence in the reference genome. This homology can lead to errors in variant identification, as sequences derived from processed pseudogenes can be incorrectly assigned to parental genes, complicating correct variant calling. In this study, we quantified the occurrence of variant calling errors associated with pseudogenes, generated by the most popular germline variant callers, namely GATK-HC, DRAGEN, and DeepVariant, when analysing 30x human whole-genome sequencing data (n = 13,307). The results show that the presence of pseudogenes can interfere with variant calling, leading to false positive identifications of potentially clinically relevant variants. Compared to other approaches, DeepVariant was the most effective in correcting these errors.

Indexed as

Germ-Line MutationPseudogenesGenetic VariationGenome, HumanHumansWhole Genome SequencingACMGprocessed pseudogenesSNPs

Identifiers

PMID39796219
PMCPMC11719938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.